Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LysM domain-containing protein 4 (LYSMD4) is a protein encoded by the LYSMD4 gene in humans (located on chromosome 15q26.3)[1][3]. The protein's primary feature is the LysM (lysin motif) domain, a globular module of about 40 amino acids known for binding polysaccharides such as peptidoglycan and chitin, mainly present in bacterial and fungal cell walls[6][2]. The precise biological function of LYSMD4 in humans is not well characterized, but the LysM domain suggests a likely role in carbohydrate recognition, possibly mediating interactions with microbial cell wall components. LYSMD4 is distinct from classical receptor or enzyme targets and has not been established as a therapeutic target[1][3][6]. Disease associations are limited and indirect, with some links to rare congenital disorders, but without established mechanistic roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LysM domain-containing protein 4 (LYSMD4).